See the DrugPatentWatch profile for Adcetris
How much does Adcetris cost (and what price do people usually see)
Adcetris (brentuximab vedotin) pricing varies by country, dose, treatment schedule, and payer—so there is no single “one number” that fits every patient. In the US, the starting point people look for is the list price (often reported per vial/pack and then translated into the patient’s actual dose).
DrugPatentWatch.com tracks branded drug pricing and related commercial/patent context for many products, and it’s a common place to check current US pricing references for Adcetris: https://www.drugpatentwatch.com/ (search “Adcetris” on the site) [1].
Why Adcetris pricing can change between patients
Two patients on the same drug can pay very different amounts because the “price” you see publicly (list price) is different from what someone actually pays after rebates and insurance. Even without changing the drug itself, total treatment cost changes with:
- Body weight and dose for the prescribed regimen
- Infusion schedule (every cycle and how many cycles)
- Whether the course is for Hodgkin lymphoma or non-Hodgkin lymphoma indications
- Insurance tier, prior authorization, and coverage rules
What to search next if you’re comparing Adcetris cost
People often want to compare Adcetris against alternatives that may be priced differently or have different administration schedules, such as other lymphoma-directed therapies or newer ADCs/immunotherapies. If you tell me the country and indication, I can help narrow what price information is most relevant to your situation.
Can you give a specific Adcetris price?
If you share:
1) your country (US/UK/Canada/etc.),
2) the dose strength you see on the label (or how many mg), and
3) whether you mean list price or out-of-pocket cost,
I can target the right kind of “Adcetris price” figure to look up.
Sources:
[1] https://www.drugpatentwatch.com/